ACES FT ACUTE CARE EXTENDED SURVEILLANCE

bullet1 FAQ

FAQ No.
Question
Answers
1 .
What data are collected?
ACES collects a high-quality clinical database includes all prior medical conditions, risk factors, and treatments as well as functional capacity medications use by name and by dose. It also captures admission and discharge diagnosis, as well as all problems, events, procedures and medication changes up until the time the patient leaves the clinical unit.
2.
How is data quality assured?
ACES prints reports that are placed directly on the chart instead of handwritten notes. It has been rigorously tested to ensure that these reports accurately reflect the data captured at the bedside. ACES research data corresponds directly to the chart, and is of the highest possible quality.
3.
Who use the data?
ACES data is intended to be useful to both providers and health care researchers. For providers, it improves efficiency by avoiding redundancy. It also provides a means of self assessment and regulation for quality assurance. The combined data set is intended as a resource for health care researchers.
4.
What resources are required for data analysis, and what are available?
I nitially, we have focused on developing the ACES software to provide a sustainable source of high-quality clinical data. Once this is accomplished, resources can be focused on assisting providers and researchers data analysis and the dissemination of results.
5.
How can we ensure adequate risk stratification for comparisons between sites?
Unlike administrative data sets, ACES will provide the detailed information needed to avoid "undercorrection" during risk stratification and adjusting for case mix.
6.
How will ACES protect the confidentiality of centers?
Individual centers have complete access to their own data, but will not be identified by name to other partners.
7.
How does ACES protect confidentiality of patients?
Personal identifying information is removed before ACES data are sent to the central database. Patients are identified by an anonymous identifier, the key for which will remain under the control of the clinical site.